
### [MONDO:0005185](http://purl.obolibrary.org/obo/MONDO_0005185)
**Label:** chronic childhood arthritis

**Subclasses:** [MONDO:0019436](http://purl.obolibrary.org/obo/MONDO_0019436) (psoriasis-related juvenile idiopathic arthritis), [MONDO:0019437](http://purl.obolibrary.org/obo/MONDO_0019437) (Enthesitis-related juvenile idiopathic arthritis), [MONDO:0019434](http://purl.obolibrary.org/obo/MONDO_0019434) (systemic-onset juvenile idiopathic arthritis), [MONDO:0018456](http://purl.obolibrary.org/obo/MONDO_0018456) (polyarticular juvenile idiopathic arthritis), [MONDO:0019435](http://purl.obolibrary.org/obo/MONDO_0019435) (rheumatoid factor-positive polyarticular juvenile idiopathic arthritis), [MONDO:0019432](http://purl.obolibrary.org/obo/MONDO_0019432) (rheumatoid factor-negative juvenile idiopathic arthritis), [MONDO:0019433](http://purl.obolibrary.org/obo/MONDO_0019433) (Oligoarticular juvenile idiopathic arthritis), [MONDO:0011429](http://purl.obolibrary.org/obo/MONDO_0011429) (juvenile rheumatoid arthritis), [MONDO:0005251](http://purl.obolibrary.org/obo/MONDO_0005251) (pauciarticular juvenile rheumatoid arthritis), [MONDO:0016618](http://purl.obolibrary.org/obo/MONDO_0016618) (rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0016617](http://purl.obolibrary.org/obo/MONDO_0016617) (rheumatoid factor-negative juvenile idiopathic arthritis with anti-nuclear antibodies), [MONDO:0019607](http://purl.obolibrary.org/obo/MONDO_0019607) (unspecified juvenile idiopathic arthritis), [MONDO:0016616](http://purl.obolibrary.org/obo/MONDO_0016616) (Oligoarticular juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0016615](http://purl.obolibrary.org/obo/MONDO_0016615) (Oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies), 

**Mapped go classes:** [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0042056](http://purl.obolibrary.org/obo/GO_0042056) (chemoattractant activity), [GO:0043268](http://purl.obolibrary.org/obo/GO_0043268) (positive regulation of potassium ion transport), [GO:0002675](http://purl.obolibrary.org/obo/GO_0002675) (positive regulation of acute inflammatory response), [GO:0010739](http://purl.obolibrary.org/obo/GO_0010739) (positive regulation of protein kinase A signaling), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0048680](http://purl.obolibrary.org/obo/GO_0048680) (positive regulation of axon regeneration), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0050715](http://purl.obolibrary.org/obo/GO_0050715) (positive regulation of cytokine secretion), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0032760](http://purl.obolibrary.org/obo/GO_0032760) (positive regulation of tumor necrosis factor production), [GO:0070207](http://purl.obolibrary.org/obo/GO_0070207) (protein homotrimerization), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0043518](http://purl.obolibrary.org/obo/GO_0043518) (negative regulation of DNA damage response, signal transduction by p53 class mediator), [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging), [GO:1902166](http://purl.obolibrary.org/obo/GO_1902166) (negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005126](http://purl.obolibrary.org/obo/GO_0005126) (cytokine receptor binding), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0001516](http://purl.obolibrary.org/obo/GO_0001516) (prostaglandin biosynthetic process), [GO:0030330](http://purl.obolibrary.org/obo/GO_0030330) (DNA damage response, signal transduction by p53 class mediator), [GO:0030890](http://purl.obolibrary.org/obo/GO_0030890) (positive regulation of B cell proliferation), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0019752](http://purl.obolibrary.org/obo/GO_0019752) (carboxylic acid metabolic process), [GO:0031666](http://purl.obolibrary.org/obo/GO_0031666) (positive regulation of lipopolysaccharide-mediated signaling pathway), [GO:0042756](http://purl.obolibrary.org/obo/GO_0042756) (drinking behavior), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0061078](http://purl.obolibrary.org/obo/GO_0061078) (positive regulation of prostaglandin secretion involved in immune response), [GO:0090238](http://purl.obolibrary.org/obo/GO_0090238) (positive regulation of arachidonic acid secretion), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0043209](http://purl.obolibrary.org/obo/GO_0043209) (myelin sheath), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0004167](http://purl.obolibrary.org/obo/GO_0004167) (dopachrome isomerase activity), [GO:0005138](http://purl.obolibrary.org/obo/GO_0005138) (interleukin-6 receptor binding), [GO:0045821](http://purl.obolibrary.org/obo/GO_0045821) (positive regulation of glycolytic process), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0050178](http://purl.obolibrary.org/obo/GO_0050178) (phenylpyruvate tautomerase activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0071157](http://purl.obolibrary.org/obo/GO_0071157) (negative regulation of cell cycle arrest), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0061081](http://purl.obolibrary.org/obo/GO_0061081) (positive regulation of myeloid leukocyte cytokine production involved in immune response), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0050778](http://purl.obolibrary.org/obo/GO_0050778) (positive regulation of immune response), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0032269](http://purl.obolibrary.org/obo/GO_0032269) (negative regulation of cellular protein metabolic process), [GO:0042327](http://purl.obolibrary.org/obo/GO_0042327) (positive regulation of phosphorylation), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0033033](http://purl.obolibrary.org/obo/GO_0033033) (negative regulation of myeloid cell apoptotic process), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0046326](http://purl.obolibrary.org/obo/GO_0046326) (positive regulation of glucose import), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0007569](http://purl.obolibrary.org/obo/GO_0007569) (cell aging), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0002035](http://purl.obolibrary.org/obo/GO_0002035) (brain renin-angiotensin system), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0002821](http://purl.obolibrary.org/obo/GO_0002821) (positive regulation of adaptive immune response), [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:2000343](http://purl.obolibrary.org/obo/GO_2000343) (positive regulation of chemokine (C-X-C motif) ligand 2 production), [GO:0002906](http://purl.obolibrary.org/obo/GO_0002906) (negative regulation of mature B cell apoptotic process), [GO:0010760](http://purl.obolibrary.org/obo/GO_0010760) (negative regulation of macrophage chemotaxis), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 52.27%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 52.27%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.63%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 37.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 37.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 37.63%


